Partner Headlines - TEVA

  1. 50 Companies Going Ex-Dividend This Week Including KO, PEP, HD, ...

    TalkMarkets
  2. Better Than The Maestro

    TalkMarkets
  3. Data Presented at ACR, Bristol-Myers Inks Immuno-Oncology Deal

    TalkMarkets
  4. A Stock Bubble

    TalkMarkets
  5. 6 Things You Need To Know About Teva's Q3 Earnings

    TalkMarkets
  6. Teva (TEVA) Q3 Earnings Top but Revenues Lag Estimates

    TalkMarkets
  7. 5 Stocks To Watch That Report Earnings Tomorrow - Tuesday, Nov. ...

    TalkMarkets
  8. Pharmaceutical Stocks Surge After Republican Victory

    TalkMarkets
  9. Buy Health Care Now? It All Depends On The Election

    TalkMarkets
  10. Generic Drugs Probe Seen As Possible 'Severe' Sector Overhang ...

    TalkMarkets
  11. S&P 500 Index Posted Its 8th Consecutive Loss

    TalkMarkets
  12. Drugs, Finance, Cars, And Fuel

    TalkMarkets
  13. Why After A Massive Run, CoLucid Shares Still Look Attractive ...

    TalkMarkets
  14. Best Stock Charts - October 30, 2016

    TalkMarkets
  15. Teva, IBM announce significant expansion of e-Health alliance ...

    TalkMarkets
  16. Global Roundup: Roche, Vale, Novo Nordisk, Teva, Benitec Et Al ...

    TalkMarkets
  17. 7 Drug Stocks To Consider As Biosimilars Pick Up Pace

    TalkMarkets
  18. Clarifying Confusion Over Mylan's EpiPen Profits

    TalkMarkets
  19. Week In Review: Teva Pays $160 Million For US/Canada Rights To ...

    TalkMarkets
  20. Has Gold Lost Its Glimmer?

    TalkMarkets
  21. The Internet Of Medical Things: 6 Stocks In Focus

    TalkMarkets
  22. How Will Healthcare Stocks Be Affected If Donald Trump Wins?

    Dividend.com
  23. How Will Healthcare Stocks Be Affected If Hillary Clinton Wins?

    Dividend.com
  24. Alder Biopharma Migraine Drug Holds Up After 6 Months

    Investors Business Daily
  25. California Leads Nation In Tech, Lifesciences IPOs

    IBD
  26. Gurus Are Buying High-Yield Stocks Like WestRock, Target

    GuruFocus
  27. Top Stocks 2015: Biotechs, Wayfair, Netflix, Amazon

    IBD
  28. Takeda Provides Update About New Business Venture in Japan with ...

    Benzinga
  29. 5 Guru Picks in Volatile Biotech Industry

    GuruFocus
  30. NWQ Managers Reduces Stakes in Microsoft, MetLife and Teva Pharmaceutical

    GuruFocus
  31. Benzinga's Top Initiations

    Benzinga
  32. GoPro PT Cut; Chipotle, Bluebird Bio Downgraded

    IBD
  33. Benzinga's Volume Movers

    Benzinga
  34. Top Performing Industries For December 1, 2015

    Benzinga
  35. US Stock Futures Edge Higher Ahead Of Economic Data

    Benzinga
  36. Teva Announces Proposed Public Offerings Of Amer Depositary Shrs ...

    Benzinga
  37. Teva, Takeda Establish Partnership in Japan; Teva to Own 51% ...

    Benzinga
  38. Teva, Heptares Announce Agreement to Discover and Develop Novel, ...

    Benzinga
  39. Benzinga's Top Upgrades

    Benzinga
  40. Pfizer, Allergan Set To Unveil $150 Billion Inversion

    IBD
  41. John Paulson Increases Holding in Teva Pharmaceutical

    GuruFocus
  42. John Paulson Keeps Gold, Buys Drug Manufacturers in Q3

    GuruFocus
  43. Mylan, Perrigo Face Off As Takeover Vote Nears

    IBD
  44. Ronald Muhlenkamp's Highest-Yielding Stocks

    GuruFocus
  45. Teva Announces Breakthrough Therapy Designation for SD-809 Granted ...

    Benzinga
  46. Allergan Beats Q3 Estimates Amid M&A, Pricing Talk

    IBD
  47. Roche Touts New MS Drug As Legacy Players Hit Snags

    IBD
  48. Allergan Confirms Pfizer Talks

    IBD
  49. Teva Pharmaceutical's

    IBD
  50. Ah the Joys of Theft - My Purloined Portfolio

    GuruFocus
  51. Here's Why Biotechs Fell On Monday

    Benzinga
  52. Teva Launches Generic Avodart Capsules in the US

    Benzinga
  53. Neurocrine Tardive Dyskinesia Drug Hits, Stock Jumps

    IBD
  54. Acorda, Allergan Make Surprise Deal On Ampyra Patent

    IBD
  55. Benzinga's M&A Chatter for Thursday October 1, 2015

    Benzinga
  56. Allergan Guidance Update Gets Mixed Reception

    IBD
  57. U.S. M&A Hits Record As Companies Try To Grow Sales

    IBD
  58. Teva Announces COPAXONE Approved in Japan for Prevention of Relapse ...

    Benzinga
  59. Teva Presents New Reslizumab Data at ERS International Congress ...

    Benzinga
  60. Hedge Fund Menta Capital's Top Stocks Include Teva Pharmaceutical, ...

    GuruFocus
  61. An ETF That Provides Shelter From Stormy Markets

    Benzinga
  62. Teva Announces U.S. Availability of ZECUITY® (sumatriptan iontophoretic ...

    Benzinga
  63. Mylan Confirms USPTO Institutes Inter Partes Review Proceedings ...

    Benzinga
  64. Allergan Modestly Tops Views

    IBD
  65. Allergan Q2 Beats, But Generics Sale Clouds Outlook

    IBD
  66. Israeli Tech Startups Attract Record Funding In Q2

    IBD
  67. 5 Top Medical Stocks Reporting Earnings This Week

    IBD
  68. Teva's Deal-Making Spurs Inflows To Israel ETFs

    Benzinga
  69. Benzinga's Top Upgrades

    Benzinga
  70. IBD 50: 10 Top Stocks Reporting Earnings This Week

    IBD
  71. These 4 Foreign Drug Stocks Have Broken Out Recently

    IBD
  72. 5 Hot Drug Stocks Top IBD's Big Cap Leaders Screen

    IBD
  73. Wakefulness Drug Xyrem Keeps Jazz Pharmaceuticals Up

    IBD
  74. Amgen Stock Clears Buy Point Ahead Of Earnings

    IBD
  75. Stocks In Rebound Mode; Icon, Cadence Break Out

    IBD
  76. Can Health Care Sector Continue its Incredible Run?

    FoxBusiness
  77. Weekly 52-Week Highs Highlight: GIS, AAP, BCR, TEVA

    GuruFocus
  78. Benzinga's Top Upgrades

    Benzinga
  79. Teva Announces European Medicines Agency (EMA) Confirms Successful ...

    Benzinga
  80. Teva Prefers Allergan Unit

    IBD
  81. Benzinga's M&A Chatter for Monday July 27, 2015

    Benzinga
  82. Stocks Fall For Fifth Straight Session On China Woes

    IBD
  83. Allergan CEO: Teva Made A 'Compelling Offer' We Couldn't Refuse

    Benzinga
  84. Market Update: Monday's Top 10 Volume Movers

    Benzinga
  85. Stocks Mired In Red, Hurt By China Weakness; Boot Barn Bounces

    IBD
  86. Market Update: Monday's Mid-Day Movers, China's Stock Market ...

    Benzinga
  87. Stocks In The Red But Off Lows As Shanghai, Europe Weigh

    IBD
  88. Teva Drops Mylan Chase To Buy Allergan Generics Unit

    IBD
  89. Benzinga's Volume Movers

    Benzinga
  90. Teva Confirms Allergan Generics Buy, Drops Mylan Bid

    IBD
  91. U.S. Stocks On Track For Weak Open As Chinese Stocks Sink

    IBD
  92. UPDATE: Mylan Issues Comment on Teva Deal to Buy Allergan's Generic ...

    Benzinga
  93. UPDATE: Teva Withdraws Proposal to Acquire Mylan

    Benzinga
  94. UPDATE: Teva to Acquire Allergan Generics for $40.5 B

    Benzinga
  95. Benzinga's Weekend M&A Chatter

    Benzinga
  96. Teva To Buy Allergan's Generic Drug Unit, Unit Worth ~$45B, Deal ...

    Benzinga
  97. Biotech IPO Boom Gaining Thrust With NantKwest Debut

    IBD
  98. Morning-after pill use increases

    IBD
  99. Novartis' Mixed Q2: Sandoz Booms, Alcon Struggles

    IBD
  100. Rapid7 IPO Pops 52%; Investors Hungry For Blue Buffalo

    IBD
Trading Center